Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib

The Janus kinases (JAK) are a group of molecules, composed of JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2), which are key components within the JAK–signal transducers and activators of transcription pathway, where cytokine receptor signaling takes place. These molecules play a foundational role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nezamololama, Novin, Fieldhouse, Keira, Metzger, Kristy, Gooderham, Melinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673622/
https://www.ncbi.nlm.nih.gov/pubmed/33240390
http://dx.doi.org/10.7573/dic.2020-8-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673622/
https://www.ncbi.nlm.nih.gov/pubmed/33240390
http://dx.doi.org/10.7573/dic.2020-8-5

Ejemplares similares